| Literature DB >> 26629778 |
Yasutaka Anraku1, Akihiro Kishimura2, Mako Kamiya3, Sayaka Tanaka4, Takahiro Nomoto5, Kazuko Toh6, Yu Matsumoto6, Shigeto Fukushima1, Daiki Sueyoshi1, Mitsunobu R Kano4, Yasuteru Urano3, Nobuhiro Nishiyama5, Kazunori Kataoka7,8.
Abstract
The design and construction of nanoreactors are important for biomedical applications of enzymes, but lipid- and polymeric-vesicle-based nanoreactors have some practical limitations. We have succeeded in preparing enzyme-loaded polyion complex vesicles (PICsomes) through a facile protein-loading method. The preservation of enzyme activity was confirmed even after cross-linking of the PICsomes. The cross-linked β-galactosidase-loaded PICsomes (β-gal@PICsomes) selectively accumulated in the tumor tissue of mice. Moreover, a model prodrug, HMDER-βGal, was successfully converted into a highly fluorescent product, HMDER, at the tumor site, even 4 days after administration of the β-gal@PICsomes. Intravital confocal microscopy showed continuous production of HMDER and its distribution throughout the tumor tissues. Thus, enzyme-loaded PICsomes are useful for prodrug activation at the tumor site and could be a versatile platform for enzyme delivery in enzyme prodrug therapy.Entities:
Keywords: drug delivery; enzymes; in vivo imaging; nanoreactors; vesicles
Mesh:
Substances:
Year: 2015 PMID: 26629778 DOI: 10.1002/anie.201508339
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336